Voronoi
VORONOI, a leading biotech in South Korea EGFR-Exon20Ins Lisenced out to ORIC Parmaceuticals in 2020 RET-Fusion Lisenced out to Inno.N in 2021 Anticipated upcoming IPO on KOSDAQ for 4Q, 2021
7-day free trial · no credit card
Verified contacts
24
available on Kipplo
LinkedIn employees
48
51 to 200 range
Open roles
—
no listings
Distinct roles
21
indexed titles
Tech stack
1
tools in use
Monthly traffic
21
organic / mo
Sign up free to see all 24 verified contacts at Voronoi
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
24 contacts with verified email or phone · masked until revealed.
- SK
Sunghwan Kim
Head of R & d · Research & Development
EmailPhone - DK
Dohyeon Kim
Ai Research Scientist · Research & Development
EmailPhone - YZ
Yin Zhang
Loxo Oncology at Lilly · Other
EmailPhone
Showing 3 of 24 verified contacts
Top roles at Voronoi
21 distinct titles indexed · top 10 shown.
- 2researcher
- 1ai research scientist
- 1ai researcher
- 1ceo of research department
- 1head of a i lab
- 1head of intellectual property (patent attorney)
- 1head of r & d
- 1human resources manager
- 1loxo oncology at lilly
- 1management support team leader
- +11more titles
Sign up to unlock all 24 contacts at Voronoi
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 24 verified contacts at Voronoi
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.